Therapies for Preexisting Cardiovascular Disease (Patient Taking Prior to Admission) Terminology

**Semantic type:** Intellectual Product

**Definition:** Terminology from the American College of Cardiology (ACC)/American Heart Association (AHA) describing the therapies taken for pre-existing cardiovascular disease prior to COVID-19 infection (from 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. Bozkurt B et al. Circ Cardiovasc Qual Outcomes. 2022; 15:e000111).

**Synonyms:** - Therapies for Preexisting Cardiovascular Disease (Patient Taking Prior to Admission)